Keybank National Association Mei Pharma, Inc. Transaction History

Keybank National Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 30, 2019	SELL	$1.92 - $4.1 $66,869 - $142,794	-34,828 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$3.39 - $4.61 $30,557 - $41,554	9,014 Added 34.92%	34,828 $150,000
Q2 2018 Aug 08, 2018	BUY	$1.89 - $4.95 $48,788 - $127,779	25,814 New	25,814 $102,000
Q4 2017 Feb 08, 2018	SELL	$1.91 - $2.83 $80,176 - $118,794	-41,977 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$2.44 - $2.91 $38,222 - $45,585	-15,665 Reduced 27.18%	41,977 $112,000

Q4 2016 May 14, 2018	BUY	N/A	57,642	57,642 $83,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.